Skip to main content
logo
CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
93.91
+0.85 (0.91%)
At close: Aug 31, 2026, 4:00 PM EDT
94.25
+0.34 (0.36%)
After-hours: Aug 31, 2026, 7:59 PM EDT

CVS Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
120,108131,99591,370100,74295,61987,26185,41956,49079,10274,142100,374101,61389,67788,62695,422122,449125,204121,506132,839136,274111,979
Market Cap Growth (YoY)
29.46%51.26%6.97%78.34%20.88%17.69%-14.90%-44.41%-11.79%-16.34%5.19%-17.02%-28.38%-27.06%-28.17%-10.15%11.81%10.61%34.65%52.43%46.52%
Enterprise Value
182,456198,719160,890171,444164,342156,001157,516129,676146,843143,027168,479165,694155,202147,582150,731173,860184,705186,389196,619202,401181,829
Last Close Price
93.91102.8170.7677.5573.0766.1464.2942.0758.2754.1272.3971.0262.2761.1565.2081.2082.6079.7986.7087.9071.89

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
24.6126.9931.1656.98-19.2616.1812.2415.7710.3113.7112.1810.3929.8923.3128.40-14.6616.5217.2316.96
Forward PE
11.5113.5610.0311.5411.3911.2411.487.779.218.069.619.398.128.048.4210.6711.0111.0312.2212.8811.11
PS Ratio
0.290.320.230.250.240.230.230.150.220.210.280.280.260.260.290.380.400.400.450.470.52
PB Ratio
1.511.651.181.341.311.131.110.751.050.991.351.331.201.211.331.711.761.611.791.811.50
P/FCF Ratio
10.2211.2312.3612.9015.2018.2614.388.93-14.0612.33-7.945.015.49-6.427.668.208.659.08
P/OCF Ratio
8.138.938.849.4710.5011.539.756.20-9.199.22-6.364.324.76-5.666.567.027.467.85
PEG Ratio
1.091.140.890.760.660.750.490.612.472.011.831.921.581.371.182.051.711.881.892.151.66

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
0.440.480.400.430.420.410.420.350.400.400.470.470.450.440.460.540.590.610.660.700.85
EV/EBITDA Ratio
10.9411.9110.4411.7211.1411.1611.2910.2810.308.819.888.988.327.927.728.719.369.5510.3210.9112.99
EV/EBIT Ratio
15.0116.3514.8417.1116.2016.7016.8816.1715.1712.2413.4211.7710.7910.229.8211.0411.9612.3213.4514.4217.15
EV/FCF Ratio
15.5216.9021.7621.9626.1232.6426.5120.50-27.1220.70-13.738.358.67-9.4711.7512.1412.8614.74

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.960.961.011.061.121.071.051.101.101.121.101.041.081.131.070.991.000.981.021.011.05
Debt / EBITDA Ratio
3.873.213.275.634.864.413.905.635.994.475.253.713.693.723.613.183.272.893.303.553.78
Debt / FCF Ratio
6.496.4910.6010.2412.9917.3113.6713.11-15.9010.05-7.094.654.40-3.654.674.694.836.38
Net Debt / Equity Ratio
0.780.780.860.920.970.880.890.950.970.900.930.890.860.890.820.770.720.780.870.840.88
Net Debt / EBITDA Ratio
3.743.744.324.744.784.914.925.705.124.164.033.683.433.503.012.762.593.033.393.424.70
Net Debt / FCF Ratio
5.305.309.008.8811.2114.3411.5411.3743.2912.818.446.545.663.693.384.092.623.733.994.035.34
Asset Turnover
1.671.581.651.591.531.481.531.501.451.411.491.431.451.451.451.401.391.321.301.26
Inventory Turnover
20.3220.4218.3319.2919.5719.6018.0818.9819.6619.2117.6617.7717.2916.9515.4015.0715.3015.0314.1314.3214.22
Quick Ratio
0.620.620.610.570.590.580.590.560.540.600.540.590.600.590.610.620.640.620.540.550.59
Current Ratio
0.870.870.870.840.830.800.820.810.800.860.810.860.860.860.920.950.940.910.880.890.94
Return on Equity (ROE)
15.21%15.46%15.75%-21.19%5.24%9.33%8.61%0.38%9.48%5.96%10.83%12.28%10.59%11.95%13.07%-18.56%16.25%12.60%6.91%8.57%
Return on Assets (ROA)
4.02%4.06%1.62%2.25%2.68%3.23%1.76%1.49%2.74%1.98%3.43%3.51%3.70%3.75%4.06%3.88%4.88%4.19%3.67%3.50%
Return on Invested Capital (ROIC)
2.14%2.14%1.15%1.60%1.16%1.53%0.92%0.70%1.46%0.98%1.84%1.91%2.01%2.03%2.22%2.79%2.44%2.21%2.03%1.70%
Return on Capital Employed (ROCE)
7.30%7.30%6.50%6.10%6.20%5.70%5.60%4.80%5.80%6.80%7.50%8.30%8.50%8.50%9.30%9.90%9.70%9.30%9.00%8.50%6.20%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
4.07%3.71%3.21%1.75%0.49%5.19%6.18%8.17%6.34%9.70%7.29%8.21%9.63%3.35%4.29%3.52%2.62%6.82%6.05%5.80%5.90%
FCF Yield
9.79%8.91%8.09%7.75%6.58%5.48%6.96%11.20%2.13%7.11%8.11%10.23%12.60%19.94%18.23%10.98%15.57%13.06%12.19%11.55%11.02%
Dividend Yield
2.83%2.59%3.76%3.43%3.64%4.02%4.14%6.32%4.46%4.69%3.43%3.41%3.80%3.78%3.46%2.71%2.60%2.63%2.36%2.27%2.09%
Payout Ratio
69.70%29.47%28.78%28.71%-84.82%47.22%50.97%962.07%48.48%75.47%38.07%34.45%41.82%36.47%30.80%-24.43%30.67%50.54%41.24%
Buyback Yield / Dilution
-1.19%-1.34%-1.19%-1.27%-0.79%-0.87%0.24%2.48%2.40%2.18%1.86%1.97%1.90%2.57%2.79%1.27%1.05%0.45%-0.45%--1.06%
Total Shareholder Return
1.65%1.25%2.57%2.16%2.85%3.15%4.37%8.80%6.87%6.87%5.29%5.38%5.70%6.35%6.25%3.98%3.66%3.08%1.91%2.27%1.02%
SEC Filings: 10-K · 10-Q